9540024

Source:http://linkedlifedata.com/resource/pubmed/id/9540024

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002272, umls-concept:C0011860, umls-concept:C0021467, umls-concept:C0021469, umls-concept:C0030705, umls-concept:C0086409, umls-concept:C0443252
pubmed:issue	3
pubmed:dateCreated	1998-5-29
pubmed:abstractText	To assess the long-term safety and effectiveness of a titrated dose of the alpha-glucosidase inhibitor miglitol (BAY m 1099) in Hispanic NIDDM patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7805975
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/1-Deoxynojirimycin, http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Glucosamine, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Imino Pyranoses, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/alpha-Glucosidases, http://linkedlifedata.com/resource/pubmed/chemical/miglitol
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0149-5992
pubmed:author	pubmed-author:ConiffR FRF, pubmed-author:DavidsonJ AJA, pubmed-author:FeigP UPU, pubmed-author:HaffnerS MSM, pubmed-author:JohnstonP SPS, pubmed-author:KrojGG
pubmed:issnType	Print
pubmed:volume	21
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	409-15
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:9540024-1-Deoxynojirimycin, pubmed-meshheading:9540024-Albuminuria, pubmed-meshheading:9540024-Blood Glucose, pubmed-meshheading:9540024-Creatinine, pubmed-meshheading:9540024-Data Interpretation, Statistical, pubmed-meshheading:9540024-Diabetes Mellitus, Type 2, pubmed-meshheading:9540024-Dose-Response Relationship, Drug, pubmed-meshheading:9540024-Double-Blind Method, pubmed-meshheading:9540024-Drug Evaluation, pubmed-meshheading:9540024-Enzyme Inhibitors, pubmed-meshheading:9540024-Female, pubmed-meshheading:9540024-Glucosamine, pubmed-meshheading:9540024-Hemoglobin A, Glycosylated, pubmed-meshheading:9540024-Hispanic Americans, pubmed-meshheading:9540024-Humans, pubmed-meshheading:9540024-Imino Pyranoses, pubmed-meshheading:9540024-Insulin, pubmed-meshheading:9540024-Lipids, pubmed-meshheading:9540024-Male, pubmed-meshheading:9540024-Middle Aged, pubmed-meshheading:9540024-Placebos, pubmed-meshheading:9540024-Postprandial Period, pubmed-meshheading:9540024-Time Factors, pubmed-meshheading:9540024-Treatment Outcome, pubmed-meshheading:9540024-alpha-Glucosidases
pubmed:year	1998
pubmed:articleTitle	Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients.
pubmed:affiliation	Bayer Pharmaceuticals, West Haven, Connecticut, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study